Geode Capital Management, LLC Anebulo Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 51,308 shares of ANEB stock, worth $99,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,308
Previous 22,777
125.26%
Holding current value
$99,024
Previous $65,000
115.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANEB
# of Institutions
14Shares Held
7.31MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$10.4 Million17.03% of portfolio
-
Lvw Advisors, LLC642KShares$1.24 Million0.26% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$986,3700.09% of portfolio
-
Morgan Stanley New York, NY399KShares$770,4920.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$304,6730.17% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $49.5M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...